Cargando…

Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation

BACKGROUND: Circular RNAs (circRNAs) are involved in regulatory processes of ubiquitination and deubiquitination in various tumors at post-transcriptional epigenetic modification level. However, the underlying mechanism and its biological functions of circRNAs in the advanced laryngeal squamous cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zheng, Sun, Anqi, Yan, Aihui, Yao, Jian, Huang, Haibo, Gao, Ziming, Han, Tao, Gu, Jia, Li, Ni, Wu, Huizhe, Li, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976408/
https://www.ncbi.nlm.nih.gov/pubmed/35366893
http://dx.doi.org/10.1186/s12943-022-01570-4
_version_ 1784680566381084672
author Wang, Zheng
Sun, Anqi
Yan, Aihui
Yao, Jian
Huang, Haibo
Gao, Ziming
Han, Tao
Gu, Jia
Li, Ni
Wu, Huizhe
Li, Kai
author_facet Wang, Zheng
Sun, Anqi
Yan, Aihui
Yao, Jian
Huang, Haibo
Gao, Ziming
Han, Tao
Gu, Jia
Li, Ni
Wu, Huizhe
Li, Kai
author_sort Wang, Zheng
collection PubMed
description BACKGROUND: Circular RNAs (circRNAs) are involved in regulatory processes of ubiquitination and deubiquitination in various tumors at post-transcriptional epigenetic modification level. However, the underlying mechanism and its biological functions of circRNAs in the advanced laryngeal squamous cell carcinoma (LSCC) remain obscure. METHODS: RNA sequencing and quantitative real-time PCR (qRT-PCR) assays were applied to screen for circRNAs differentially expressed in LSCC tissues and cell lines. The candidate RNA-binding proteins and target signalling pathway were detected by RNA pull-down and mass spectrometry, in situ hybridization (ISH), immunohistochemistry (IHC), qRT-PCR assays, and bioinformatics analysis. The functional roles of these molecules were investigated using in vitro and in vivo experiments including EdU, transwell, wound healing, western blot assays, and the xenograft mice models. The molecular mechanisms were identified using RNA pull-down assays, RNA immunoprecipitation (RIP), Co-IP, ISH, Ubiquitination assay, bioinformatics analysis, and the rescue experiments. RESULTS: Here, we unveil that microtubule cross-linking factor 1 circRNA (circMTCL1, circ0000825) exerts its critical oncogenic functions by promoting complement C1q-binding protein (C1QBP)-dependent ubiquitin degradation and subsequently activating Wnt/β-catenin signalling in laryngeal carcinoma initiation and development. Specifically, circMTCL1 was remarkably up-regulated in the paired tissues of patients with LSCC (n = 67), which predicted a worse clinical outcome. Functionally, circMTCL1 exerted oncogenic biological charactersistics by promoting cell proliferative capability and invasive and migrative abilities. Ectopic circMTCL1 augumented cell proliferation, migration, and invasion of LSCC cells, and this effect could be reversed by C1QBP knocking down in vitro and in vivo. Mechanistically, circMTCL1 directly recruited C1QBP protein by harboring the specific recognized sequence (+ 159 − + 210), thereby accelerating the translation of C1QBP expression by inhibiting its ubiquitin–proteasome-mediated degradation. Importantly, the direct interaction of C1QBP with β-catenin protein was enhanced via suppressing the β-catenin phosphorylation and accelerating its accumulation in cytoplasm and nucleus. CONCLUSION: Our findings manifested a novel circMTCL1-C1QBP-β-catenin signaling axis involving in LSCC tumorigenesis and progression, which shed new light on circRNAs-ubiquitous acidic glycoprotein mediated ubiquitin degradation and provided strategies and targets in the therapeutic intervention of LSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01570-4.
format Online
Article
Text
id pubmed-8976408
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89764082022-04-03 Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation Wang, Zheng Sun, Anqi Yan, Aihui Yao, Jian Huang, Haibo Gao, Ziming Han, Tao Gu, Jia Li, Ni Wu, Huizhe Li, Kai Mol Cancer Research BACKGROUND: Circular RNAs (circRNAs) are involved in regulatory processes of ubiquitination and deubiquitination in various tumors at post-transcriptional epigenetic modification level. However, the underlying mechanism and its biological functions of circRNAs in the advanced laryngeal squamous cell carcinoma (LSCC) remain obscure. METHODS: RNA sequencing and quantitative real-time PCR (qRT-PCR) assays were applied to screen for circRNAs differentially expressed in LSCC tissues and cell lines. The candidate RNA-binding proteins and target signalling pathway were detected by RNA pull-down and mass spectrometry, in situ hybridization (ISH), immunohistochemistry (IHC), qRT-PCR assays, and bioinformatics analysis. The functional roles of these molecules were investigated using in vitro and in vivo experiments including EdU, transwell, wound healing, western blot assays, and the xenograft mice models. The molecular mechanisms were identified using RNA pull-down assays, RNA immunoprecipitation (RIP), Co-IP, ISH, Ubiquitination assay, bioinformatics analysis, and the rescue experiments. RESULTS: Here, we unveil that microtubule cross-linking factor 1 circRNA (circMTCL1, circ0000825) exerts its critical oncogenic functions by promoting complement C1q-binding protein (C1QBP)-dependent ubiquitin degradation and subsequently activating Wnt/β-catenin signalling in laryngeal carcinoma initiation and development. Specifically, circMTCL1 was remarkably up-regulated in the paired tissues of patients with LSCC (n = 67), which predicted a worse clinical outcome. Functionally, circMTCL1 exerted oncogenic biological charactersistics by promoting cell proliferative capability and invasive and migrative abilities. Ectopic circMTCL1 augumented cell proliferation, migration, and invasion of LSCC cells, and this effect could be reversed by C1QBP knocking down in vitro and in vivo. Mechanistically, circMTCL1 directly recruited C1QBP protein by harboring the specific recognized sequence (+ 159 − + 210), thereby accelerating the translation of C1QBP expression by inhibiting its ubiquitin–proteasome-mediated degradation. Importantly, the direct interaction of C1QBP with β-catenin protein was enhanced via suppressing the β-catenin phosphorylation and accelerating its accumulation in cytoplasm and nucleus. CONCLUSION: Our findings manifested a novel circMTCL1-C1QBP-β-catenin signaling axis involving in LSCC tumorigenesis and progression, which shed new light on circRNAs-ubiquitous acidic glycoprotein mediated ubiquitin degradation and provided strategies and targets in the therapeutic intervention of LSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01570-4. BioMed Central 2022-04-02 /pmc/articles/PMC8976408/ /pubmed/35366893 http://dx.doi.org/10.1186/s12943-022-01570-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Zheng
Sun, Anqi
Yan, Aihui
Yao, Jian
Huang, Haibo
Gao, Ziming
Han, Tao
Gu, Jia
Li, Ni
Wu, Huizhe
Li, Kai
Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation
title Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation
title_full Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation
title_fullStr Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation
title_full_unstemmed Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation
title_short Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation
title_sort circular rna mtcl1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting c1qbp ubiquitin degradation and mediating beta-catenin activation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976408/
https://www.ncbi.nlm.nih.gov/pubmed/35366893
http://dx.doi.org/10.1186/s12943-022-01570-4
work_keys_str_mv AT wangzheng circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation
AT sunanqi circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation
AT yanaihui circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation
AT yaojian circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation
AT huanghaibo circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation
AT gaoziming circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation
AT hantao circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation
AT gujia circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation
AT lini circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation
AT wuhuizhe circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation
AT likai circularrnamtcl1promotesadvancedlaryngealsquamouscellcarcinomaprogressionbyinhibitingc1qbpubiquitindegradationandmediatingbetacateninactivation